Navigation Links
Samarion(SM) to Demonstrate Unprecedented Fall Prevention Component of Enterprise Quality Improvement System for LTC Facilities at the AAHSA 2008 Annual Meeting & Exposition
Date:9/16/2008

Samarion CEO and CAST Commissioner Mark Rodgers Slated as Featured Panelist

for 'Falls and Technology' Education Session

PHILADELPHIA, Sept. 16 /PRNewswire/ -- Stop Falls Now! That is not just a worthwhile message or future goal that Samarion brings to the AAHSA 2008 Annual Meeting and Exposition, but is now a reality. For the first time, Samarion will present live demonstrations of its unprecedented fall prevention system at this show.

Beyond slogans or theory, LTC providers will be able to see firsthand how the SamarionSolution will equip them to significantly prevent unassisted bed exit falls. Falls represent the No. 1 cause of serious accidental injury and deaths in elder home care and LTC facilities. Unlike any other fall management device or notification system, Samarion's restraint-free fall prevention component provides caregivers with the ability to intervene with residents before harmful falls occur. With the SamarionSolution, residents and their families will have an unparalleled level of safety, security and peace of mind.

"The statistics of nursing home falls is staggering," said Samarion Chief Executive Officer Mark E. Rodgers. "While the statistics are overwhelming, we have to remember that behind the numbers are wonderful seniors who deserve the safety and security that technology can now provide. Although we cannot possibly stop every fall, the value of saving one fall is beyond measure. We look forward to working with compassionate caregivers in reversing the fall trend and dramatically improving the quality of life for the millions of seniors in long term care," continued Rodgers.

The SamarionSolution is reliable, easy-to-use transformational technology providing restraint-free fall prevention; unsafe wandering and elopement prevention; abuse and neglect prevention; staff management and facility monitoring; and a family-and-friends communications system that greatly improves the quality of the lives of nursing home residents and their loved ones.

To experience the SamarionSolution first hand, please visit Samarion Booth #1529. Our team of experts, along with owners and administrators of nursing homes with initial implementations of SamarionSolution, will be on hand to answer questions, demonstrate the system, sign up customers, and schedule installations.

Rodgers, also a CAST Commissioner, will be a featured panelist for the "Falls and Technology" education session, to be held on Sunday, Oct. 12, from 3:30-5:30 p.m.

Samarion, a privately-held corporation dedicated to improving the quality of elder care, was recently recognized as an "Emerging High-Growth Company to Watch."

Samarion CEO Mark Rodgers will be available for interviews during the Oct. 12-15 show by phone or in person at the Pennsylvania Convention Center in Philadelphia, Pa.


'/>"/>
SOURCE Samarion
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Samarion(SM) Announces Second Outcome Based Study Partner Site for LTC Industrys Only Enterprise Quality Improvement System
2. Samarion(SM) Announces Formation of Outcome Based Study Team for Industrys Only Enterprise Quality Improvement System
3. David B. Samadi, MD, Demonstrates Robotic Prostate Surgery During Live Webcast, August 13, 2008
4. New CDC Report Demonstrates Urgency for All States and Cities to Become Smokefree
5. CCNY researchers demonstrate effectiveness of contrast agent Cytate in detectcing prostate cancer
6. GoAmerica(R) and AT&T to Demonstrate Fast, Effective 10-Digit Interoperability Between Video Relay Providers
7. New Survey Demonstrates Increased Awareness of the Dangers of Meth Use
8. Dartmouth-Hitchcock Medical Center Evaluation Findings Demonstrate Masimo Patient SafetyNet(TM) Delivers Improvements in Clinical Outcomes and Patient Safety on General Care Floors
9. New AMITIZA 8 mcg phase III studies demonstrated overall symptom improvement in adult women
10. Data from Pooled Analyses Demonstrates Welchol, Combined with Metformin- or Sulfonylurea-Based Therapy, Significantly Lowers Blood Glucose in Adults with Type 2 Diabetes
11. Duska Therapeutics Sponsored University of Pennsylvania Study Demonstrates ATP Improves Sperm Motility and In Vitro Fertilization in Animals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2017)... ... May 26, 2017 , ... via seating ... mesh back 24/7 task chair specifically designed for clinical areas. Genie Copper Mesh ... to partner with Cupron® to provide customers with a game changing chair that ...
(Date:5/26/2017)... (PRWEB) , ... May 26, 2017 , ... Rob Lowe ... An upcoming production of the series is on hiking in American. Viewers can reconnect ... of the great benefits of hiking. , Many consumers have looked for an inventive ...
(Date:5/26/2017)... ... 26, 2017 , ... “Just What Happened in the Garden of Eden”: retells the stories of ... is the creation of published author, Penelope Colt, mother, trader, horse farmer, artist and a ... when she was three. At six, they moved to Dayton, Ohio, where Penny graduated ...
(Date:5/24/2017)... ... May 24, 2017 , ... Dr. Alan I. Benvenisty, ... in New York City. He is known for his distinguished expertise and experience in ... Dr. Benvenisty holds sub-specialty training in treating renovascular disease and aortic aneurysm . ...
(Date:5/24/2017)... OH (PRWEB) , ... May 24, 2017 , ... Patients ... in Cortland, OH, can now meet with Dr. Joseph Bedich for a consultation, with ... while simultaneously improving their oral health and functionality. , Dr. Bedich offers ...
Breaking Medicine News(10 mins):
(Date:5/18/2017)...  Two Bayer U.S. Pharmaceutical leaders received top awards ... 28 th Woman of the Year ... longstanding mission of furthering the advancement and impact of ... Cindy Powell-Steffen , senior director of brand activation and ... Libby Howe , a regional business manager for New ...
(Date:5/15/2017)... Inc., a privately-held CNS pharmaceutical company based in ... disease (PD), has enrolled the first patient in the RASMET ... study involving patients with PD and taking place at 12 ... period. The first stage is open label and involves single ... Denver , Boca Raton ...
(Date:5/10/2017)... Inc. (Nasdaq: HOLX ) announced today the ... April 1, 2017 .   GAAP diluted earnings per ... prior year period as the sale of the blood ... diluted EPS of $0.50 increased 6.4%.  Revenue of $715.4 ... Excluding the effects of blood screening and the acquired ...
Breaking Medicine Technology: